Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapyUri Kopylov, David Drobne, Nicola Imperatore et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 80
Success and safety of high infliximab trough levels in inflammatory bowel diseaseDavid Drobne, A. Smid, Tina Kurent et al.|Scandinavian Journal of Gastroenterology|2018Cited by 46